Bibliografía del artículo
1. Liao L, Allen LA, Whellan DJ. Economic burden of heart failure in the elderly. Pharmacoeconomics 26:447-62, 2008.
2. Cowie MR, Mosterd A, Wood DA y col. The epidemiology of heart failure. Eur Heart J 18:208-25, 1997.
3. Ferreira Montero JI. Insuficiencia cardíaca: mayor morbilidad, menor mortalidad. ¿Vamos por el buen camino? Rev Esp Cardiol 53:767-9, 2000.
4. Huynh BC, Rovner A, Rich MW. Long term survival in elderly patients hospitalized for heart failure. 14-year follow-up from a prospective randomized trial. Arch Intern Med 166:1892-8, 2006.
5. McDermott MM, Feinglass J, Lee PI y col. Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure. Am Heart J 134:728-36, 1997.
6. Mosterd A, Cost B, Hoes AW y col. The prognosis of heart failure in the general population. The Rotterdam Study. Eur Heart J 22:1318-27, 2001.
7. Gustafsson F, Torp-Pedersen C, Seibaek M, Burchardt H, Kober L for the Diamond study group. Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure. Eur Heart J 25:1711-7, 2004.
8. Van Veldhuisen DJ, Boomsma F, De Kam PJ y col. Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure. Eur Heart J 19:753-60, 1998.
9. Dutka DP, Olivotto I, Ward S y col. Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure. Eur Heart J 16:1223-30, 1995.
10. Konstam MA. Progress in heart failure management? Lessons from the real world. Circulation 102:1076-8, 2000.
11. Ruiz Ruiz FJ, Samperiz Legarre P, Ruiz Laiglesia FJ y col. Influencia de la edad en la mortalidad de pacientes con insuficiencia cardíaca. An Med Intern 22:424-8, 2005.
12. Senni M, Rodeheffer RJ, Tribouilloy CM y col. Use of echocardiography in the management of congestive heart failure in the community. J Am Coll Cardiol 33:164-70, 1999.
13. Bellotti P, Badano LP, Acquarone N y col. Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. The Oscur study. Eur Heart J 22:596-604, 2001.
14. Pulignano G, Del Sindaco D, Tavazzi L y col. Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). Am Heart J 143:45-55, 2002.
15. Gómez Sánchez MA, Bañuelos de Lucas C, Ribera Casado JM, Pérez Casal F. Avances en cardiología geriátrica. Rev Esp Cardiol 59(Supl.1):105-9, 2006.
16. Forteza-Rey Borralleras J. Comorbilidad e insuficiencia cardíaca. Rev Clin Esp 201(Supl.1):16-21, 2001.
17. Permanyer Miralda G, Soriano N, Brotons C, y col. Características basales y determinantes de la evolución en pacientes ingresados por insuficiencia cardíaca en un hospital general. Rev Esp Cardiol 55:571-8, 2002.
18. Dahlström U. Frequent non-cardiac comorbidities in patients with chronic heart failure. Eur J Heart Fail 7:309-16, 2005.
19. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 322:1561-6, 1990.
20. Himmelmann A. Hypertension an important precursor of heart failure. Blood Press 8:253-60, 1999.
21. Brownlee M, Cerami A, Vlassara H. Advenced glycosylationed products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-21, 1988.
22. Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 27:699-703, 2004.
23. Ni H, Nauman DJ, Hershberger RE. Managed care and outcomes of hospitalisation among elderly patients with congestive heart failure. Arch Intern Med 158:1231-6, 1998.
24. McCullough PA, Hollander JE, Nowak RM y col. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med 10:198-204, 2003.
25. Salperter SR, Ormiston TM, Salpeter EE. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 137:715-25, 2002.
26. Kotlyar E, Keogh AM, MacDonald PS, Arnold RH, McCaffrey DJ, Glanville AR. Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma. J Heart Lung Transplant 21:1290-5, 2002.
27. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE inhibitor Trials. JAMA 1195; 273:1450-6.
28. The Consensus Trail Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Coopertive North Scandinavian Enalapril Survival Study (Consensus). N Engl J Med 316:1429-35, 1987.
29. Mangoni AA, Jackson SHD. The implications of a growing evidence base for drug use in elderly patients. Part 2. ACE inhibitors and angiotensin receptor blockers in heart failure and high cardiovascular risk patients. Br J Clin Pharmacol 61:502-512, 2006.
30. Pilote L, Abrahamowicz M, Eisenberg M, Humphries K, Behlouli H, Tu JV. Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure. CMAJ 178:1303-11, 2008.
31. Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J on behalf on PEP-CHF Investigators. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27:2338-45, 2006.
32. The Cardiac Insufficiency Bisoprolol Study (CIBIS). A randomized trial of beta-blockade in heart failure. Circulation 90:1765-73, 1994.
33. The Cardiac Insuffciency Bisoprolol Study II (CIBIS-II). A randomized trial. Lancet 353:9-13, 1999.
34. Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Effect of metoprolol CR/XL in chronic heart failure. Lancet 353:2001-7, 1999.
35. Packer M, Cotas AJ, Fowler MB y col. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651-8, 2001.
36. The BEST study. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 344:1659-67, 2001.
37. Flather MD, Shibata MC, Cotas AJ y col. Randomized trial to determinate the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patiens with heart failure (Seniors). Eur Heart J 26:215-25, 2005.
38. Pfeffer MA, Swedberg K, Granger CB y col. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362:759-66, 2003.
39. Galve E. Fármacos antialdosterónicos: su papel en la insuficiencia cardiaca. Med Clin 130:30-4, 2008.
40. Kjekshus J, Apetrei E, Barrios V y col; the CORONA group. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357:2248-61, 2007.
41. Khush KK, Waters DD, Bittner V y col. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. Circulation 115:576-83, 2007.
42. DeSelvey DL. Statins and heart failure. Am J Geriatr Cardiol 17:130-1, 2008.
43. Rich MW, McSherry F, Williford WO, Yusuf S on behalf Digitalis Investigation Group. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. J Am Coll Cardiol 38:806-13, 2001.
44. Aronow WS. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients. Heart Dis 5:279-94, 2003.
45. Antorrena Miranda MI, Conthe P. Tratamiento de la insuficiencia cardiaca en el anciano. Inf Ter Sist Nac Salud 31:75-87, 2007.
46. Grimm W. Outcomes of elderly heart failure recipients of ICD and CRT. Int J Cardiol 125:154-60, 2008.
47. The antiarrhythmics versus implantable defibrillators (AVID) investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576-83, 1997.
48. Connoly SJ, Gent M, Roberts RS y col. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101:1297-302, 2000.
49. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102:748-54, 2000.
50. Moss AJ, Zareba W, Hall WJ y col. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877-83, 2002.
51. Bardy GH, Lee KL, Mark DB y col, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225-37, 2005.
52. Healey JS, Hallstrom AP, Kuck KH y col. Role of implantable defibrillator among elderly patients with a history of life threatening ventricular arrhythmias. Eur Heart J 28:1746-9, 2007.
53. Bristow MR, Saxon LA, Boehmer y col, for the Comparison of Medical Theraphy, Pacing and Defibrillation in Heart Failure (Companion) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140-50, 2004.
54. Cleland JG, Daubert JC, Erdmann E y col, for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539-49, 2005.